Aug 13, 2026 07:05AM
Aug 6, 2026 04:15PM
Jul 13, 2026 07:30AM
Jul 1, 2026 07:05AM
Jun 24, 2026 07:30AM
Jun 24, 2026 07:30AM
Jun 16, 2026 07:31AM COGNITION Therapeutics receives patent notice for zervimesine to 2045
Jun 16, 2026 07:30AM
Jun 1, 2026 07:30AM
May 21, 2026 07:30AM
May 21, 2026 07:30AM
May 14, 2026 07:31AM
May 14, 2026 07:30AM
May 7, 2026 04:15PM Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update
Mar 31, 2026 04:31PM
Mar 31, 2026 04:30PM
Mar 26, 2026 07:31AM
Mar 26, 2026 07:30AM
Mar 17, 2026 07:31AM
Mar 17, 2026 07:30AM
Mar 2, 2026 07:31AM Cognition Therapeutics advances DLB psychosis program for zervimesine
Mar 2, 2026 07:30AM
Feb 5, 2026 07:31AM
Feb 5, 2026 07:30AM
Jan 27, 2026 07:31AM
Jan 27, 2026 07:30AM
Jan 6, 2026 07:30AM
Jan 6, 2026 07:30AM Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies
Dec 3, 2025 07:30AM
Dec 3, 2025 07:30AM
Dec 1, 2025 07:31AM
Dec 1, 2025 07:30AM
Nov 6, 2025 07:30AM
Aug 12, 2025 04:00PM
Aug 12, 2025 04:00PM Cognition Therapeutics Receives End-of-Phase 2 Meeting Minutes Confirming Alignment with U.S. FDA on Registrational Path for Zervimesine (CT1812) in Alzheimer’s Disease
Aug 7, 2025 04:00PM
Jul 29, 2025 07:30AM
Jul 21, 2025 07:31AM
Jul 21, 2025 07:30AM
Jul 16, 2025 07:31AM
Jul 16, 2025 07:30AM
Jul 14, 2025 07:07AM H.C. Wainwright Reiterates Buy Rating on Cognition Therapeutics (CGTX)
Jul 10, 2025 07:31AM
Jul 10, 2025 07:30AM
Jun 26, 2025 06:45AM
Jun 25, 2025 07:30AM
May 7, 2025 07:30AM
Mar 24, 2025 06:42AM
Mar 20, 2025 07:00AM Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
Feb 26, 2025 07:00AM

329,987 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All